Search clinical trials for: Zoledronate

Total 56 results

424 General Military Hospital

Recruiting

Sequential Therapies After Osteoanabolic Treatment (START)

Osteoporosis, Postmenopausal

Greece, Germany, Italy
National Institute of Allergy and Infectious Diseases...

Unknown

Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

HIV Infections | Osteoporosis | Osteopenia

United States
Washington University School of Medicine

Completed

Exome Sequencing for Atypical Femoral Fractures

Osteoporosis | Atypical Femoral Fractures | Bisphosphonate Therapy
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

Malignant Neoplasm | Musculoskeletal Complications

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid

Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast Carcinoma

United States
National Cancer Institute (NCI)

Completed

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Aarhus University Hospital
University of Aarhus; Amgen

Completed

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis (ZOLARMAB)

Osteoporosis

Denmark
Aarhus University Hospital

Recruiting

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2

Osteoporosis, Postmenopausal

Denmark
University of California, San Francisco
Novartis

Completed

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
University of Wisconsin, Madison

Completed

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Breast Cancer

United States
First Affiliated Hospital, Sun Yat-Sen University

Terminated

Bone Loss Treatment From Adjuvant Zoledronate Efficacy (BLAZE)

Breast Neoplasms | Bone Loss

China
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
Ottawa Hospital Research Institute

Active, not recruiting

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL) (REaCT-ZOL)

Early-stage Breast Cancer

Canada
Mario Negri Institute for Pharmacological Research
Associazione Italiana per la Ricerca sul Cancro

Terminated

Pre-operative Zoledronate in Triple Negative Breast Cancer

Breast Cancer

Italy
University of California, San Francisco
National Cancer Institute (NCI)

Terminated

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Cervical Cancer | Precancerous Condition

United States
Per Aspenberg

Unknown

Initial Fixation of Bisphosphonate-coated Dental Implants

Pre-integration Failure of Dental Implant

Sweden
Azienda Socio Sanitaria Territoriale degli Spedali...

Recruiting

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients (BonEnza)

Prostate Cancer | Bone Metastases

Italy
Hoffmann-La Roche
Roche Pharma AG

Terminated

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (COMPARE)

Multiple Myeloma

Germany
Barbara Ann Karmanos Cancer Institute
United States Department of Defense

Completed

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Prostate Cancer

United States
Medical University Innsbruck

Completed

Bisphosphonate Therapy in MONA Spectrum Disorder

Pain | Fracture | Bone Density
Axsome Therapeutics, Inc.

Unknown

CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1 (CREATE-1)

Reflex Sympathetic Dystrophy | Complex Regional Pain Syndrome

United States, United Kingdom, Australia, Canada
The University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong; Queen Mary Hospital, Hong Kong; United... and other collaborators

Recruiting

The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients (Zoo-P)

Pneumonia | Hip Fractures

Hong Kong
Yonsei University

Recruiting

A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

Osteoporosis

Korea, Republic of
Ottawa Hospital Research Institute

Recruiting

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Breast Cancer | Castration-resistant Prostate Cancer

Canada
McGill University Health Centre/Research Institute...
Crohn's and Colitis Foundation

Completed

Zoledronate for Osteopenia in Pediatric Crohn's

Crohn's Disease | Osteoporosis | Osteopenia

Canada
University of Aarhus

Recruiting

The Optimised Use of Romozosumab Study (OPTIMIST)

Osteoporosis

Denmark
University of Wisconsin, Madison

Recruiting

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Acute Myeloid Leukemia | Hodgkin Lymphoma | Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Neuroblastoma | Rhabdomyosarcoma | Primitive Neuroectodermal Tumor | Myeloproliferative Syndrome

United States
Ottawa Hospital Research Institute

Completed

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases (REaCT-BTA)

Breast Cancer | Prostate Cancer | Metastasis

Canada
Lene Bergendal Solberg
Vestre Viken Hospital Trust; Diakonhjemmet Hospital; Roche Diagnostics

Recruiting

Zoledronate Early to Hip Fracture Patients - Safe and Effective? (ZEBRA)

Hip Fractures | Osteoporosis

Norway
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Ductal Carcinoma in Situ

United States
St. Louis University
Johns Hopkins University; Massachusetts General Hospital; Beth Israel Deaconess... and other collaborators

Recruiting

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Giant Cell Tumor of Bone

United States, Canada, India
Soroka University Medical Center
Tel-Aviv Sourasky Medical Center

Completed

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole

Breast Cancer

Israel
Wales Cancer Trials Unit
Velindre NHS Trust

Unknown

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Breast Cancer | Metastatic Cancer | Hypercalcemia of Malignancy

United Kingdom
Novartis Pharmaceuticals

Completed

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Breast Cancer

United States
424 General Military Hospital

Recruiting

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) (EURODEC)

Osteoporosis, Postmenopausal

Greece, France, Germany, Italy
Xeolas Pharmaceuticals Limited

Recruiting

A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction (XEOLAS)

Bone Loss, Alveolar

Spain
Shenzhen People's Hospital

Recruiting

Denosumab vs Zoledronate After Lumbar Fusion

Osteopenia | Lumbar Spondylolisthesis

China
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Pain | Breast Cancer | Metastatic Cancer | Hypercalcemia of Malignancy
Shenzhen People's Hospital

Completed

Denosumab vs Zoledronate After Vertebroplasty

Denosumab Allergy | Zoledronic Acid Allergy

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Prostate Cancer | Osteoporosis

United States, Canada
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Completed

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

Breast Cancer | Bone Metastases

United States
University of Aarhus

Terminated

The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta

Osteogenesis Imperfecta

Denmark
M.D. Anderson Cancer Center
Novartis Pharmaceuticals

Completed

Zoledronate With Atorvastatin in Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma

United States
University of Michigan Rogel Cancer Center
Novartis; Aventis Pharmaceuticals

Completed

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Hormone-Refractory Prostate Cancer

United States
M.D. Anderson Cancer Center
Novartis

Completed

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Lymphoma | Non-Hodgkin's Lymphoma

United States
Mario Negri Institute for Pharmacological Research
Associazione Italiana per la Ricerca sul Cancro

Completed

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer (YAPPETIZER)

Triple Negative Breast Cancer

Italy
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Osteoporosis | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome

United States
Novartis Pharmaceuticals

Completed

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Breast Neoplasms | Osteoporosis

United States, Puerto Rico
Emory University

Recruiting

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma (Aflac-NBL-2002)

Neuroblastoma | Refractory Neuroblastoma | Relapsed Neuroblastoma

United States
Postgraduate Institute of Medical Education and...

Completed

Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus

Diabetes Complications | Charcot Arthropathy

India

Search clinical trials for: Zoledronate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations